Latest Investments News

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.

HealthCo Healthcare and Wellness REIT reported a sharp increase in half-year losses to $15.4 million, alongside a portfolio reduction and steady funds from operations, highlighting a complex transition phase.

Unibail-Rodamco-Westfield delivered robust FY-2024 results with a 7% rise in like-for-like EBITDA and adjusted recurring EPS surpassing guidance, supported by strong retail and convention business performance. The company also announced a 40% increase in its proposed dividend, reflecting confidence in its financial health and strategic asset management.

Embelton Limited reported a notable 25.4% decline in revenue for the half-year ended December 31, 2024, yet managed a 23% increase in net profit, underscoring effective cost controls amid a challenging construction market. The company declared an interim dividend consistent with the prior period, signaling confidence despite subdued outlook.

Evolution Mining Limited has announced a fully franked ordinary dividend of AUD 0.07 per share for the half-year ending December 2024, accompanied by a Dividend Reinvestment Plan offering a 5% discount.

Desane Group Holdings has secured a lease extension with Brisbane City Council for its Wacol industrial property, guaranteeing $4.5 million in rental income through to 2030. This deal underscores confidence in Desane’s strategic positioning in Brisbane’s industrial market.

Hancock & Gore Limited (ASX: HNG) showcased a transformative year at its 121st AGM, spotlighting a strategic merger with Schoolblazer that creates a leading global uniforms platform and signals a new phase of growth and portfolio simplification.

Prophecy International Holdings has posted a record half-year revenue of $11.6 million for H1 FY25, driven by strong demand for its AI-enabled cybersecurity and data integration products. The company’s transition to subscription models and expansion into new global markets underpin a positive outlook.

Recce Pharmaceuticals has temporarily paused trading of its securities, signaling a potentially significant development pending further disclosure.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

VHM Limited has unveiled a staged development plan for its Goschen Rare Earths and Mineral Sands Project, targeting first production by late 2026 and a scalable expansion to 5Mtpa by 2029 with robust financial returns.

Krakatoa Resources has provided a detailed update on its Zopkhito Antimony-Gold Project in Georgia, revealing significant exploration data and a strategic plan to advance towards JORC-compliant resources.